Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Veeva Systems Inc (VEEV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,904,851
  • Shares Outstanding, K 143,440
  • Annual Sales, $ 685,570 K
  • Annual Income, $ 141,970 K
  • 36-Month Beta 1.54
  • Price/Sales 21.56
  • Price/Cash Flow 92.42
  • Price/Book 14.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/18
See More
  • Average Estimate 0.29
  • Number of Estimates 7
  • High Estimate 0.30
  • Low Estimate 0.28
  • Prior Year 0.15
  • Growth Rate Est. (year over year) +93.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.70 +19.85%
on 08/22/18
107.77 -3.58%
on 09/17/18
+16.82 (+19.31%)
since 08/21/18
3-Month
73.47 +41.43%
on 07/31/18
107.77 -3.58%
on 09/17/18
+20.35 (+24.35%)
since 06/21/18
52-Week
52.17 +99.18%
on 02/09/18
107.77 -3.58%
on 09/17/18
+47.77 (+85.09%)
since 09/21/17

Most Recent Stories

More News
Veeva (VEEV) Up 16.1% Since Last Earnings Report: Can It Continue?

Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

VEEV : 103.91 (+0.81%)
Here's Why You Should Buy Intuitive Surgical (ISRG) Now

Strength in the surgical platform and a string of developments make Intuitive Surgical (ISRG) a promising pick.

ATHN : 136.60 (-1.51%)
VEEV : 103.91 (+0.81%)
MASI : 122.50 (+0.41%)
ISRG : 556.77 (-0.79%)
Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.

ATHN : 136.60 (-1.51%)
BDX : 261.52 (-0.14%)
VEEV : 103.91 (+0.81%)
ISRG : 556.77 (-0.79%)
Abbott Banks on New Approvals and Buyouts, Competition Rife

Abbott's (ABT) receipt of FDA approval for XIENCE Sierra coronary stent system as well as a reimbursement approval in Japan for the same device will help it revive the dull Vascular business.

ABT : 69.05 (+0.38%)
ATHN : 136.60 (-1.51%)
VEEV : 103.91 (+0.81%)
ISRG : 556.77 (-0.79%)
3 Top Stocks From the Booming US Medical Products Industry

The U.S. Medical Products industry is sturdy on solid focus on technological advancement.

SRDX : 72.80 (unch)
ATHN : 136.60 (-1.51%)
VEEV : 103.91 (+0.81%)
ICUI : 265.50 (-0.09%)
QDEL : 64.84 (-5.19%)
Cerner Integrated Platform Implemented by Spectrum Health

Spectrum Health selects Cerner's (CERN) Cerner Integrated Platform to treat psychological disorders.

CERN : 63.82 (-0.76%)
ATHN : 136.60 (-1.51%)
VEEV : 103.91 (+0.81%)
ISRG : 556.77 (-0.79%)
Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now

AngioDynamics (ANGO) to benefit from a solid product portfolio. However, the company???s core Peripheral Vascular business has been sluggish.

ATHN : 136.60 (-1.51%)
VEEV : 103.91 (+0.81%)
ANGO : 23.51 (+0.38%)
ISRG : 556.77 (-0.79%)
Veeva's Vault CDMS to Unify Clinical Data in Single Platform

Veeva's (VEEV) cloud-based applications' market prospects bright.

CERN : 63.82 (-0.76%)
ATHN : 136.60 (-1.51%)
VEEV : 103.91 (+0.81%)
ISRG : 556.77 (-0.79%)
The Single Biggest Retail Opportunity of 2018

Apple recently became a $1 trillion company, truly a titan of the modern age. By far the most valuable publicly-traded company in the United States, Apple enjoys unrivaled supremacy with its 13-figure...

SHOP : 161.52 (-3.38%)
BB : 10.41 (+0.68%)
PSTG : 26.88 (-2.43%)
VEEV : 103.91 (+0.81%)
CLS : 10.90 (-1.00%)
Here's Why You Should Invest in Masimo (MASI) Right Now

A raised guidance for 2018 and positive developments make Masimo (MASI) a lucrative choice for investors.

ATHN : 136.60 (-1.51%)
VEEV : 103.91 (+0.81%)
MASI : 122.50 (+0.41%)
ISRG : 556.77 (-0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade VEEV with:

Business Summary

Veeva Systems Inc. operates as a provider of industry-specific, cloud-based software solutions for the life sciences industry. It offers enterprise applications, a multichannel platform, customer relationship management, and content management solutions. The Company provides its solutions to pharmaceutical,...

See More

Key Turning Points

2nd Resistance Point 105.50
1st Resistance Point 104.70
Last Price 103.91
1st Support Level 102.93
2nd Support Level 101.96

See More

52-Week High 107.77
Last Price 103.91
Fibonacci 61.8% 86.53
Fibonacci 50% 79.97
Fibonacci 38.2% 73.41
52-Week Low 52.17

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar